Literature DB >> 23935324

Community acquired quinolone-resistant Escherichia coli pyelonephritis complicated with multiple renal abscesses: a case report.

M Katsiari1, C Nikolaou, Z Roussou, C Triantopoulou, D Apessou, Ed Platsouka, A Maguina.   

Abstract

Acute pyelonephritis is a potentially organ-damaging and life-threatening infection. A 37-year old woman was admitted to Intensive Care Unit in septic shock and multi-organ failure due to acute pyelonephritis with systemic bacterial dissemination caused by a quinolone-resistant Escherichia coli. The patient, a previously healthy woman, reported recurrent episodes of urinary tract infection in the previous 3 years, which were treated with quinolones. Treatment course with broad-spectrum antimicrobial agents reversed her septic shock and multi-organ failure. However, pyelonephritis progressed to intrarenal and perirenal abscesses formation. The patient fully recovered after surgical removal of the infected kidney.

Entities:  

Keywords:  acute pyelonephritis; nephrectomy; quinolone-resistant Escherichia coli; renal abscesses; septic shock

Year:  2012        PMID: 23935324      PMCID: PMC3738619     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  8 in total

1.  Medical treatment of renal and perirenal abscesses: CT evaluation.

Authors:  L Dalla Palma; F Pozzi-Mucelli; V Ene
Journal:  Clin Radiol       Date:  1999-12       Impact factor: 2.350

2.  Renal and perirenal abscesses in patients with otherwise anatomically normal urinary tracts.

Authors:  Tung Shu; Justin M Green; Eduardo Orihuela
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

3.  Renal and perinephric abscesses: analysis of 65 consecutive cases.

Authors:  Rafael Ferreira Coelho; Edison D Schneider-Monteiro; José Luís Borges Mesquita; Eduardo Mazzucchi; Antonio Marmo Lucon; Miguel Srougi
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

Review 4.  Perinephric and intrarenal abscesses.

Authors:  W R Morgan; L M Nyberg
Journal:  Urology       Date:  1985-12       Impact factor: 2.649

5.  Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.

Authors:  Willize E van der Starre; Cees van Nieuwkoop; Sunita Paltansing; Jan W van't Wout; Geert H Groeneveld; Martin J Becker; Ted Koster; G Hanke Wattel-Louis; Nathalie M Delfos; Hans C Ablij; Eliane M S Leyten; Jeanet W Blom; Jaap T van Dissel
Journal:  J Antimicrob Chemother       Date:  2010-12-01       Impact factor: 5.790

6.  Renal abscesses measuring 5 cm or less: outcome of medical treatment without therapeutic drainage.

Authors:  Seung Hwan Lee; Hyun Jin Jung; Sang Yol Mah; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

7.  Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.

Authors:  S Chaniotaki; P Giakouppi; L S Tzouvelekis; D Panagiotakos; M Kozanitou; G Petrikkos; A Avlami; A C Vatopoulos
Journal:  Clin Microbiol Infect       Date:  2004-01       Impact factor: 8.067

8.  Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.

Authors:  Karla M Killgore; Kristi L March; B Joseph Guglielmo
Journal:  Ann Pharmacother       Date:  2004-05-18       Impact factor: 3.154

  8 in total
  2 in total

1.  Exploring the Therapeutic Efficacy of Zingerone Nanoparticles in Treating Biofilm-Associated Pyelonephritis Caused by Pseudomonas aeruginosa in the Murine Model.

Authors:  Karuna Sharma; Sunil Kumar Bose; Sanjay Chhibber; Kusum Harjai
Journal:  Inflammation       Date:  2020-12       Impact factor: 4.092

2.  Exploring the Anti-quorum Sensing and Antibiofilm Efficacy of Phytol against Serratia marcescens Associated Acute Pyelonephritis Infection in Wistar Rats.

Authors:  Ramanathan Srinivasan; Ramar Mohankumar; Arunachalam Kannappan; Veeramani Karthick Raja; Govindaraju Archunan; Shunmugiah Karutha Pandian; Kandasamy Ruckmani; Arumugam Veera Ravi
Journal:  Front Cell Infect Microbiol       Date:  2017-12-05       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.